Anika Therapeutics, Inc. (ANIK)
20.64
-0.46
(-2.18%)
USD |
NASDAQ |
Aug 31, 16:00
20.64
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Cash from Operations (TTM) : 5.977M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.977M |
| March 31, 2026 | 6.472M |
| December 31, 2025 | 11.19M |
| September 30, 2025 | 8.133M |
| June 30, 2025 | 6.279M |
| March 31, 2025 | 5.399M |
| December 31, 2024 | 5.403M |
| September 30, 2024 | 7.459M |
| June 30, 2024 | 8.928M |
| March 31, 2024 | 1.704M |
| December 31, 2023 | -1.788M |
| September 30, 2023 | -4.945M |
| June 30, 2023 | -8.721M |
| March 31, 2023 | 2.66M |
| December 31, 2022 | 4.409M |
| September 30, 2022 | 8.40M |
| June 30, 2022 | 7.753M |
| March 31, 2022 | 8.959M |
| December 31, 2021 | 8.397M |
| September 30, 2021 | 6.512M |
| June 30, 2021 | 10.32M |
| March 31, 2021 | 9.589M |
| December 31, 2020 | 13.06M |
| September 30, 2020 | 23.50M |
| June 30, 2020 | 27.69M |
| Date | Value |
|---|---|
| March 31, 2020 | 29.59M |
| December 31, 2019 | 37.00M |
| September 30, 2019 | 34.00M |
| June 30, 2019 | 34.79M |
| March 31, 2019 | 33.79M |
| December 31, 2018 | 34.92M |
| September 30, 2018 | 31.88M |
| June 30, 2018 | 33.14M |
| March 31, 2018 | 34.94M |
| December 31, 2017 | 40.81M |
| September 30, 2017 | 39.68M |
| June 30, 2017 | 38.89M |
| March 31, 2017 | 31.58M |
| December 31, 2016 | 23.80M |
| September 30, 2016 | 33.23M |
| June 30, 2016 | 30.82M |
| March 31, 2016 | 42.76M |
| December 31, 2015 | 39.06M |
| September 30, 2015 | 38.55M |
| June 30, 2015 | 34.54M |
| March 31, 2015 | 30.37M |
| December 31, 2014 | 39.98M |
| September 30, 2014 | 33.23M |
| June 30, 2014 | 35.85M |
| March 31, 2014 | 32.69M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Perspective Therapeutics, Inc. | -93.07M |
| MiMedx Group, Inc. | 46.13M |
| ABVC BioPharma, Inc. | -2.691M |
| Enovis Corp. | 270.10M |
| Edwards Lifesciences Corp. | 1.720B |